Patent · US Active

Tetrahydro-quinazolinone derivatives as TANK and PARP inhibitors

US9339503B2 · kind B2 · utility

2Cited by

3References

5Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Hans-Peter Buchstaller · Griesheim, DE
Christina Esdar · Darmstadt, DE
Birgitta Leuthner · Darmstadt, DE

Key dates

Filing date	Jan 14, 2013
Grant date	May 17, 2016
Priority date	—
Expiry date	Jan 14, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula Iin which U, V and W have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.